Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ?65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.

Basit Öğe Kaydı
dc.authoridMUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628
dc.authoridSantoro, Armando/0000-0003-1709-9492
dc.authoridOzyilkan, Ozgur/0000-0001-8825-4918
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidShitara, Kohei/AAA-3877-2021
dc.authorwosidBilancia, Domenico/AAO-9167-2021
dc.authorwosidMUSTAFA, ÖZGÜROĞLU/A-8234-2016
dc.authorwosidJimenez-Fonseca, Paula/AAA-1272-2020
dc.authorwosidSantoro, Armando/J-9594-2018
dc.authorwosidOzyilkan, Ozgur/AAD-2817-2021
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorShitara, Kohei
dc.contributor.authorDoi, Toshihiko
dc.contributor.authorHosaka, Hisashi
dc.contributor.authorThuss-Patience, Peter C.
dc.contributor.authorSantoro, Armando
dc.contributor.authorJimenez-Fonseca, Paula
dc.contributor.authorLongo, Federico
dc.date.accessioned2024-06-12T11:22:27Z
dc.date.available2024-06-12T11:22:27Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.4037
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2019.37.15_suppl.4037
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25937
dc.identifier.volume37en_US
dc.identifier.wosWOS:000487345805225en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleTrifluridine/tipiracil (FTD/TPI) in patients (pts) aged ?65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu